Prevalence of hepatitis C in two inpatient psychiatry populations

REFERENCES

• Razali K, Thein HH, Bell J . Modelling the hepatitis C virus epidemic in Australia. Drug & Alcohol Dependence 2007; 91: 228–235.
   PubMed Web of Science ®Google Scholar
• Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine 2006; 144: 705–714.
   PubMed Web of Science ®Google Scholar
• Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. International Journal of Medical Science 2006; 3: 41–46.
   PubMedGoogle Scholar
• Alter MJ. Epidemiology of hepatitis C virus infection. World Journal of Gastroenterology 2007; 13: 2436–2441.
   PubMed Web of Science ®Google Scholar
• Hepatitis C Virus Projections Working Group. Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2006. Sydney, NSW: National Centre for HIV Epidemiology and Clinical Research, University of NSW; 2006.
   Google Scholar
• Davidson S, Judd F, Jolley D, Hocking B, Thompson S, Hyland B. Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill. Australian & New Zealand Journal of Psychiatry 2001; 35: 203–209.
   PubMed Web of Science ®Google Scholar
• Osher FC, Goldberg RW, McNary SW . Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatric Services 2003; 54: 842–847.
   PubMed Web of Science ®Google Scholar
• Al Jurdi RK, Burruss JW. Prevalence of hepatitis C in psychiatric institutions. Psychosomatics 2003; 44: 439–440.
   Google Scholar
• Dinwiddie SH, Shicker L, Newman T. Prevalence of hepatitis C among psychiatric patients in the public sector. American Journal of Psychiatry 2003; 160: 172–174.
   PubMedGoogle Scholar
• Rosenberg SD, Drake RE, Brunette MF, Wolford GL, Marsh BJ. Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disorders. AIDS 2005; 19 Suppl 3: S26–S33.
   PubMed Web of Science ®Google Scholar
• Sawayama Y, Hayashi J, Kakuda K . Hepatitis C virus infection in institutionalized psychiatric patients: possible role of transmission by razor sharing. Digestive Diseases & Sciences 2000; 45: 351–356.
   PubMedGoogle Scholar
• Essock SM, Dowden S, Constantine NT . Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatric Services 2003; 54: 836–841.
   PubMed Web of Science ®Google Scholar
• Lacey C, Ellen S, Devlin H, Wright E, Mijch A. Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours. Australasian Psychiatry 2007; 15: 315–319.
   PubMed Web of Science ®Google Scholar
• Poynard T, Yuen M-F, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362: 2095–2100.
   PubMed Web of Science ®Google Scholar
• Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. American Journal of Psychiatry 2000; 157: 867–876.
   PubMed Web of Science ®Google Scholar
• Hepatitis C Council of NSW. Aussie Snapshot, 2007 [accessed 2008 May 23]; Available from URL: http://www.hepatitisc.org.au/quickref/documents/AussieSnapshot.pdf.
   Google Scholar
• Seccull A, Richmond J, Thomas B, Herrman H. Hepatitis C in people with mental illness: how big is the problem and how do we respond? Australasian Psychiatry 2006; 14: 374–378.
   PubMedGoogle Scholar
• Schiff ER. Hepatitis C and alcohol. Hepatology 1997; 26: 39S–42S.
   PubMed Web of Science ®Google Scholar
• Vento S, Cainelli F. Does hepatitis C virus cause severe liver disease only in people who drink alcohol? The Lancet Infectious Diseases 2002; 2: 303–309.
   Google Scholar
• Batista-Neves SC, Quarantini LC, de Almeida AG . High frequency of unrecognized mental disorders in HCV-infected patients. General Hospital Psychiatry 2008; 30: 80–82.
   PubMedGoogle Scholar
• Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in patients with chronic hepatitis C. Journal of Psychosomatic Research 2000; 49: 311–317.
   PubMed Web of Science ®Google Scholar
• Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. Journal of Clinical Psychiatry 2003; 64: 708–714.
   PubMed Web of Science ®Google Scholar
• Bonaccorso S, Marino V, Biondi M, Grimaldi F, Ippoliti F, Maes M. Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. Journal of Affective Disorders 2002; 72: 237–241.
   PubMed Web of Science ®Google Scholar
• Miyaoka H, Otsubo T, Kamijima K, Ishii M, Onuki M, Mitamura K. Depression from interferon therapy in patients with hepatitis C. American Journal of Psychiatry 1999; 156: 1120.
   Web of Science ®Google Scholar
• Horikawa N, Yamazaki T, Izumi N, Uchihara M. Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study. General Hospital Psychiatry 2003; 25: 34–38.
   PubMed Web of Science ®Google Scholar
• Dieperink E, Ho SB, Thuras P, Willenbring ML. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003; 44: 104–112.
   PubMed Web of Science ®Google Scholar
• Yovtcheva SP, Rifai MA, Moles JK, Van der Linden BJ. Psychiatric comorbidity among hepatitis C-positive patients. Psychosomatics 2001; 42: 411–415.
   PubMed Web of Science ®Google Scholar
• Australian Bureau of Statistics. Socio-economic Indexes for Areas (SEIFA). [Data cube: Excel spreadsheet] 2006. Viewed on 26 March 2008; Available from URL: http://www.abs.gov.au/ausstats/[email protected]/mf/2033.0.55.001/
   Google Scholar
• Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: Detailed Findings. AIHW (Drug Statistics Series No 16), 2005.
   Google Scholar